HOME >> BIOLOGY >> NEWS
Microbiology organization elects Zhou fellow

OAK RIDGE, Tenn., June 8, 2005 An Oak Ridge National Laboratory scientist researcher of microbial genomics and ecology has been elected a Fellow of the American Academy of Microbiology.

Jizhong Zhou is a distinguished research and development staff scientist in microbial genomics and ecology in the Environmental Sciences Division of the Department of Energy's Oak Ridge National Laboratory. He was inducted as a Fellow June 8 in Atlanta during the 105th General Meeting of the American Society of Microbiology.

His research has concentrated on pioneering advances and leadership in developing genomics technologies that can aid in the research challenges of such areas as bioremediation, global changes and carbon.

Fellows are elected through a highly selective, annual peer-reviewed process based on their records of scientific achievement and original contributions that have advanced the study of microbiology.

The American Academy of Microbiology is the honorific leadership group within the American Society for Microbiology, which is the world's oldest life science organization and the only group of its kind devoted entirely to microbiologists and the science of microbiology.

Zhou has earned numerous awards and honors during his career, including a 2001 Presidential Early Career Award for Scientists and Engineers. He also earned ORNL's 2001 Environmental Sciences Division Distinguished Scientific Achievement Award.

He earned a bachelor's degree in plant pathology and entomology, along with a master's in mathematical ecology, from China's Hunan Agricultural University. He earned a doctorate in molecular biology from Washington State University.

Zhou and his wife, Cindy Shi, who is a financial officer in ORNL's Life Sciences Division, are residents of Oak Ridge. They have a daughter, Elizabeth, who is a student at Washington University in St. Louis, and a son, Benjamin, who attends Oak Ridge's Jefferson Middle School.
'"/>

Contact: Fred Strohl
strohlhf@ornl.gov
865-574-4165
DOE/Oak Ridge National Laboratory
9-Jun-2005


Page: 1 2

Related biology news :

1. Tips from the Journals of the American Society for Microbiology
2. Tips from the Journals of the American Society for Microbiology
3. Tips from the Journals of the American Society for Microbiology
4. Tips from the Journals of the American Society for Microbiology
5. LA Times reporters receive Public Communications Award from American Society for Microbiology
6. American Society for Microbiology to host 107th General Meeting in Toronto
7. Tips from the Journals of the American Society for Microbiology
8. Tips from the Journals of the American Society for Microbiology
9. Tips from the Journals of the American Society for Microbiology
10. Tips from the Journals of the American Society for Microbiology
11. Tips from the journals of the American Society for Microbiology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Microbiology organization elects Zhou fellow

(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: